We are live on
!
Find out more
X
Xponance Portfolio holdings
AUM
$16.3B
1-Year Est. Return
44.61%
This Fund
S&P 500
This Quarter
Est. Return
+12.21%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$6.84B
AUM Growth
+$670M
(+11%)
Cap. Flow
+$122M
Cap. Flow
% of AUM
1.79%
Top 10 Holdings %
Top 10 Hldgs %
29.79%
Holding
1,272
New
38
Increased
861
Reduced
283
Closed
30
Avg Time Held
8.8
quarters
Top 10 Avg Time Held
8.9
quarters
Top 20 Avg Time Held
6.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$7.81M |
| 2 |
Microsoft
MSFT
|
+$7.66M |
| 3 |
Costco
COST
|
+$4.11M |
| 4 |
Goldman Sachs
GS
|
+$4.03M |
| 5 |
Moody's
MCO
|
+$4.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SIVB
SVB Financial Group
SIVB
|
+$2.66M |
| 2 |
GE Aerospace
GE
|
+$2.45M |
| 3 |
Public Service Enterprise Group
PEG
|
+$2.32M |
| 4 |
Caterpillar
CAT
|
+$2M |
| 5 |
Simon Property Group
SPG
|
+$1.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.93% |
| 2 | Healthcare | 13.19% |
| 3 | Consumer Discretionary | 11.73% |
| 4 | Financials | 10.87% |
| 5 | Industrials | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1226
Ur-Energy
URG
$354M
| $12.7K | ﹤0.01% |
11,969
| – | – |
2022 Q2
3 quarters
|
|
1227
Inovio Pharmaceuticals
INO
$103M
| $11.6K | ﹤0.01% |
1,178
| – | – |
2022 Q2
3 quarters
|
|
1228
Blend Labs
BLND
$226M
| $10.7K | ﹤0.01% |
10,780
| – | – |
2022 Q3
2 quarters
|
|
1229
Firy Inc
FIRY
$206M
| $10.7K | ﹤0.01% |
900
| – | – |
2021 Q2
7 quarters
|
|
1230
Ocugen
OCGN
$300M
| $10.5K | ﹤0.01% |
12,360
| – | – |
2022 Q2
3 quarters
|
|
1231
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $10.1K | ﹤0.01% |
+34
| New | +$14.4K |
2023 Q1
0 quarters
|
|
|
FFAI
1232
Faraday Future Intelligent Electric
FFAI
$6.8M
| – | – |
0
| – | – |
2022 Q4
1 quarter
|
|
1233
DELISTED
Sonder
SOND
| $8.23K | ﹤0.01% |
544
| – | – |
2022 Q3
2 quarters
|
|
1234
Nektar Therapeutics
NKTR
$1.29B
| $7.27K | ﹤0.01% |
689
| – | – |
2022 Q3
2 quarters
|
|
|
BINI
1235
DELISTED
Bollinger Innovations
BINI
| – | – |
0
| – | – |
2022 Q3
2 quarters
|
|
|
RIDE
1236
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
| $6.63K | ﹤0.01% |
667
| – | – |
2022 Q4
1 quarter
|
|
1237
GeneDx Holdings
WGS
$1.94B
| $5.78K | ﹤0.01% |
+480
| New | +$6.4K |
2023 Q1
0 quarters
|
|
1238
Cenntro
CENN
$8.62M
| $4.81K | ﹤0.01% |
17
| – | – |
2022 Q3
2 quarters
|
|
|
BBIG
1239
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
| $4.23K | ﹤0.01% |
658
| – | – |
2022 Q3
2 quarters
|
|
1240
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $3.25K | ﹤0.01% |
357
| – | – |
2022 Q2
3 quarters
|
|
1241
DELISTED
NeueHealth
NEUE
| $2.41K | ﹤0.01% |
137
| – | – |
2022 Q1
4 quarters
|
|
1242
VistaGen Therapeutics
VTGN
$9.53M
| $1.42K | ﹤0.01% |
380
| – | – |
2022 Q2
3 quarters
|
|
1243
Cracker Barrel
CBRL
$1.37B
| – | – |
-3,441
| Closed | -$326K | – |
|
1244
Cytokinetics
CYTK
$8.57B
| – | – |
-4,699
| Closed | -$215K | – |
|
1245
Dycom Industries
DY
$8.13B
| – | – |
-4,784
| Closed | -$448K | – |
|
1246
Independent Bank
INDB
$3.64B
| – | – |
-2,623
| Closed | -$221K | – |
|
1247
JBG SMITH
JBGS
$653M
| – | – |
-13,299
| Closed | -$252K | – |
|
1248
Kennametal
KMT
$2.39B
| – | – |
-12,558
| Closed | -$302K | – |
|
1249
Madrigal Pharmaceuticals
MDGL
$10.4B
| – | – |
-729
| Closed | -$212K | – |
|
1250
Adamas Trust
ADAM
$684M
| – | – |
-5,305
| Closed | -$54.3K | – |
|
Similar funds
PCM
LPC
MFG
PAM
BS
BBVA
NMO
PAS
Xponance's Q1 2023 Portfolio in Review
As of Q1 2023, Xponance held 1,272 positions worth $6.84B, up 11% from $6.17B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Xponance's Q1 2023 filing shows 38 new, 861 increased, 283 reduced and 30 closed positions. Its largest new stake was GE HealthCare: 46,842 shares worth $3.84M. The largest sale was SVB Financial Group, an estimated $2.66M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Xponance's largest Q1 2023 buy was GE HealthCare: 46,842 shares worth $3.84M.
- Xponance added most to Apple in Q1 2023, an estimated $7.81M increase.
- Xponance's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $2.45M.
- Xponance fully exited SVB Financial Group in Q1 2023, selling an estimated $2.66M.
- Xponance's ten largest holdings make up 30% of its $6.84B portfolio in Q1 2023.
- Xponance opened 38 new positions and closed 30 in Q1 2023.
- Xponance's portfolio value rose 11% quarter-over-quarter to $6.84B.
Based on Xponance's 13F filing for Q1 2023, filed 18 Apr 2023.